Aparna Kalyan

Hematology | Oncology
675 N St Clair St Ste 21-100
Galter Pavilion
Chicago, IL 60611

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications

Addition of High-Dose Vitamin D3 to Standard Treatment in Patients With Metastatic Colorectal Cancer: The SOLARIS Randomized Clinical Trial (Alliance A021703).

Addition of High-Dose Vitamin D3 to Standard Treatment in Patients With Metastatic Colorectal Cancer: The SOLARIS Randomized Clinical Trial (Alliance A021703).

Journal: JAMA
Published: August 03, 2026

KRAS Subtype Modifies Outcomes with Immunomodulatory Therapy in Advanced Pancreatic Ductal Adenocarcinoma: Evidence from Early-Phase Trials.

KRAS Subtype Modifies Outcomes with Immunomodulatory Therapy in Advanced Pancreatic Ductal Adenocarcinoma: Evidence from Early-Phase Trials.

Journal: Cancers
Published: May 17, 2026

A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.

A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 19, 2026

Yttrium-90 Transarterial Radioembolization for Intrahepatic Cholangiocarcinoma: A Comprehensive Review.

Yttrium-90 Transarterial Radioembolization for Intrahepatic Cholangiocarcinoma: A Comprehensive Review.

Journal: Journal of gastrointestinal cancer
Published: December 26, 2025

Baseline Hemoglobin Predicts Oncologic Outcomes in Intrahepatic Cholangiocarcinoma Treated With Yttrium-90 Radioembolisation: A Retrospective Cohort Study of 136 Patients.

Baseline Hemoglobin Predicts Oncologic Outcomes in Intrahepatic Cholangiocarcinoma Treated With Yttrium-90 Radioembolisation: A Retrospective Cohort Study of 136 Patients.

Journal: Journal of medical imaging and radiation oncology
Published: November 25, 2025

Characterization of Patients with Unresectable Hepatocellular Carcinoma in REFLECT Who Achieved Tumor Response or Alpha-Fetoprotein Response When Treated with Lenvatinib.

Characterization of Patients with Unresectable Hepatocellular Carcinoma in REFLECT Who Achieved Tumor Response or Alpha-Fetoprotein Response When Treated with Lenvatinib.

Journal: Liver cancer
Published: October 24, 2025

Liver Transplant using the RAPID technique in a patient with colorectal liver metastases: Case report of a first in the United States.

Liver Transplant using the RAPID technique in a patient with colorectal liver metastases: Case report of a first in the United States.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Published: October 01, 2025

A retrospective analysis of taxane-based chemotherapy in small bowel adenocarcinoma.

A retrospective analysis of taxane-based chemotherapy in small bowel adenocarcinoma.

Journal: The oncologist
Published: September 29, 2025

Rates of Successful Bridging or Downstaging and Safety of Segmental Radioembolization for Hepatocellular Carcinoma in Patients with Baseline Hyperbilirubinemia.

Rates of Successful Bridging or Downstaging and Safety of Segmental Radioembolization for Hepatocellular Carcinoma in Patients with Baseline Hyperbilirubinemia.

Journal: Journal of vascular and interventional radiology : JVIR
Published: July 01, 2025

Escalated Segmental and Modified Radiation Lobectomy Dosing for Yttrium-90 Radioembolization of Liver-Dominant Metastatic Colorectal Cancer: 10-year Outcomes.

Escalated Segmental and Modified Radiation Lobectomy Dosing for Yttrium-90 Radioembolization of Liver-Dominant Metastatic Colorectal Cancer: 10-year Outcomes.

Journal: Clinical colorectal cancer
Published: January 21, 2025

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers.

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 13, 2024

A Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal Cancer.

A Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal Cancer.

Journal: Journal of gastrointestinal cancer
Published: December 01, 2024
Showing 1-12 of 60

Last Updated: 09/26/2026